These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 36215065)

  • 1. Physician Perspectives on Reducing Curative Cancer Treatment Intensity for Populations Underrepresented in Clinical Trials.
    Rocque GB; Andrews C; Lawhon VM; Ingram SA; Frazier RM; Smith ML; Wagner LI; Zubkoff L; Wallner LP; Wolff AC
    Oncologist; 2022 Dec; 27(12):1067-1073. PubMed ID: 36215065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oncologist-Reported Barriers and Facilitators to Enrolling Patients in Optimization Trials That Test Less Intense Cancer Treatment.
    Rocque GB; Andrews C; Lawhon VM; Frazier R; Ingram SA; Smith ML; Wagner LI; Zubkoff L; Tung N; Wallner LP; Wolff AC
    JCO Oncol Pract; 2023 Feb; 19(2):e263-e273. PubMed ID: 36473142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Facilitators and barriers to reducing chemotherapy for early-stage breast cancer: a qualitative analysis of interviews with patients and patient advocates.
    Andrews C; Childers TC; Wiseman KD; Lawhon V; Ingram S; Smith ML; Wolff AC; Wagner L; Rocque GB
    BMC Cancer; 2022 Feb; 22(1):141. PubMed ID: 35120494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physicians' Hierarchy of Tumor Biomarkers for Optimizing Chemotherapy in Breast Cancer Care.
    Thannickal HH; Eltoum N; Henderson NL; Wallner LP; Wagner LI; Wolff AC; Rocque GB
    Oncologist; 2024 Jan; 29(1):e38-e46. PubMed ID: 37405703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What Is Important When Making Treatment Decisions in Metastatic Breast Cancer? A Qualitative Analysis of Decision-Making in Patients and Oncologists.
    Rocque GB; Rasool A; Williams BR; Wallace AS; Niranjan SJ; Halilova KI; Turkman YE; Ingram SA; Williams CP; Forero-Torres A; Smith T; Bhatia S; Knight SJ
    Oncologist; 2019 Oct; 24(10):1313-1321. PubMed ID: 30872466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Should we be talking about guidelines with patients? A qualitative analysis in metastatic breast cancer.
    Hull O; Niranjan SJ; Wallace AS; Williams BR; Turkman YE; Ingram SA; Williams CP; Smith T; Knight SJ; Bhatia S; Rocque GB
    Breast Cancer Res Treat; 2020 Nov; 184(1):115-121. PubMed ID: 32737711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patient perspectives on chemotherapy de-escalation in breast cancer.
    Rocque GB; Williams CP; Andrews C; Childers TC; Wiseman KD; Gallagher K; Tung N; Balch A; Lawhon VM; Ingram SA; Brown T; Kaufmann T; Smith ML; DeMichele A; Wolff AC; Wagner L
    Cancer Med; 2021 May; 10(10):3288-3298. PubMed ID: 33932097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Barriers and facilitators for clinical trial participation among diverse Asian patients with breast cancer: a qualitative study.
    Lee GE; Ow M; Lie D; Dent R
    BMC Womens Health; 2016 Jul; 16():43. PubMed ID: 27449505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Health-related quality of life in early breast cancer.
    Groenvold M
    Dan Med Bull; 2010 Sep; 57(9):B4184. PubMed ID: 20816024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The analysis of physicians' work: announcing the end of attempts at in vitro fertilization].
    Santiago-Delefosse M; Cahen F; Coeffin-Driol C
    Encephale; 2003; 29(4 Pt 1):293-305. PubMed ID: 14615699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A qualitative study to evaluate physician attitudes regarding omission of surgery among exceptional responders to neoadjuvant systemic therapy for breast cancer (NRG-CC006).
    Gharzai LA; Szczygiel LA; Shumway DA; Bandos H; Julian TB; Mamounas EP; White J; De Los Santos JF; Basik M; Ganz PA; Jagsi R
    Breast Cancer Res Treat; 2021 Jun; 187(3):777-784. PubMed ID: 33740205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Barriers to Participation in Therapeutic Clinical Trials as Perceived by Community Oncologists.
    Wong AR; Sun V; George K; Liu J; Padam S; Chen BA; George T; Amini A; Li D; Sedrak MS
    JCO Oncol Pract; 2020 Sep; 16(9):e849-e858. PubMed ID: 32240068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trust but Verify: Exploring the Role of Treatment-Related Information and Patient-Physician Trust in Shared Decision Making Among Patients with Metastatic Breast Cancer.
    Niranjan SJ; Wallace A; Williams BR; Turkman Y; Williams CP; Bhatia S; Knight S; Rocque GB
    J Cancer Educ; 2020 Oct; 35(5):885-892. PubMed ID: 31062280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medical oncologist perspectives on palliative care reveal physician-centered barriers to early integration.
    Kruser TJ; Kruser JM; Gross JP; Moran M; Kaiser K; Szmuilowicz E; Kircher SM
    Ann Palliat Med; 2020 Sep; 9(5):2800-2808. PubMed ID: 32787372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perspectives on barriers and facilitators to minority recruitment for clinical trials among cancer center leaders, investigators, research staff, and referring clinicians: enhancing minority participation in clinical trials (EMPaCT).
    Durant RW; Wenzel JA; Scarinci IC; Paterniti DA; Fouad MN; Hurd TC; Martin MY
    Cancer; 2014 Apr; 120 Suppl 7(0 7):1097-105. PubMed ID: 24643647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implementing the 2009 Institute of Medicine recommendations on resident physician work hours, supervision, and safety.
    Blum AB; Shea S; Czeisler CA; Landrigan CP; Leape L
    Nat Sci Sleep; 2011; 3():47-85. PubMed ID: 23616719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A prospective analysis of the influence of older age on physician and patient decision-making when considering enrollment in breast cancer clinical trials (SWOG S0316).
    Javid SH; Unger JM; Gralow JR; Moinpour CM; Wozniak AJ; Goodwin JW; Lara PN; Williams PA; Hutchins LF; Gotay CC; Albain KS
    Oncologist; 2012; 17(9):1180-90. PubMed ID: 22723506
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.